Asia-Pacific biologics market is estimated to grow at a CAGR of 9.2% during the forecast period. Some pivotal factors accelerating market growth include the rising prevalence of cancer and increasing launches of biologics therapy. As per the World Health Organization (WHO), in Asia, the number of new cancer incidences expected to be reported in 2020 will be nearly 9.5 million. This, in turn, is leading to an increasing demand for biologics drugs which acts as an immune system substance that supports to augment the body’s ability to fight against cancer. Biologics comprises a comprehensive range of drugs that particularly target cancer cells, encourage the immune response, and support the recovery from cancer treatment. These drugs are normally utilized in combination with other therapies, including chemotherapy.
Get Free Sample link @ https://www.omrglobal.com/request-sample/asia-pacific-biologics-market
Asia-Pacific biologics market is segmented based on product and application. Based on the product, the market is segmented into antibody therapeutics, vaccines, cell therapy, gene therapy, and others. A large number of biologics available in the market are monoclonal antibodies and several products are in the pipeline. Over the decades, advances in the improvement of the humanization of monoclonal antibodies have been witnessed, which, in turn, improves efficacy and decreasing immunogenicity. Monoclonal antibodies are regarded as highly targeted drugs, binds to the cancerous cells, and poison the tumor to destroy it. One instance of a biological drug includes Trastuzumab, which is utilized in particular for metastatic breast cancer in women. Another instance is Rituxan, which is utilized to support the treatment of non-Hodgkin’s lymphoma. Based on application, the market is segmented into cancer, autoimmune diseases, infectious diseases, and others.
A full report of Asia-Pacific Biologics Market available @ https://www.omrglobal.com/industry-reports/asia-pacific-biologics-market
- Market Coverage
- Market number available for – 2022-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others
Market Segmentation
Asia-Pacific Biologics Market by Product
- Antibody Therapeutics
- Vaccines
- Cell Therapy
- Gene Therapy
- Others
Asia-Pacific Biologics Market by Application
- Cancer
- Autoimmune Diseases
- Infectious Diseases
- Others
Regional Analysis
- China
- India
- Japan
- Rest of Asia-Pacific
Company Profiles
- AbbVie, Inc.
- Overview
- Product Portfolio
- Recent Activities
- Amgen, Inc.
- Aurobindo Pharma, Ltd.
- Biocon, Ltd.
- Biological E. Ltd.
- Boehringer Ingelheim GmbH
- Cipla, Ltd.
- Daiichi Sankyo Company, Ltd.
- Eli Lilly and Co.
- Hoffman-La Roche AG
- Innovent Biologics, Inc.
- Intas Pharmaceuticals, Ltd.
- Shanghai Henlius Biotech Inc. (Shanghai Fosun Pharmaceutical Co., Ltd.)
The Report Covers
- Comprehensive research methodology of the Asia-Pacific biologics market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the Asia-Pacific biologics market.
- Insights about market determinants which are stimulating the Asia-Pacific biologics market.
- Detailed and extensive market segments with regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/asia-pacific-biologics-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
